nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—liver cancer	0.497	0.569	CbGaD
Amifostine—ALPL—liver cancer	0.377	0.431	CbGaD
Amifostine—ALPPL2—bile duct—liver cancer	0.0423	0.647	CbGeAlD
Amifostine—ALPPL2—gall bladder—liver cancer	0.00902	0.138	CbGeAlD
Amifostine—ALPPL2—embryo—liver cancer	0.00572	0.0874	CbGeAlD
Amifostine—ALPL—Endochondral Ossification—IFT88—liver cancer	0.00534	0.12	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—IFT88—liver cancer	0.00454	0.102	CbGpPWpGaD
Amifostine—ALPL—liver—liver cancer	0.00299	0.0457	CbGeAlD
Amifostine—ENPP1—liver—liver cancer	0.00274	0.042	CbGeAlD
Amifostine—ALPPL2—liver—liver cancer	0.00264	0.0404	CbGeAlD
Amifostine—ENPP1—Endochondral Ossification—ALPL—liver cancer	0.00178	0.04	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—SHC3—liver cancer	0.00171	0.0384	CbGpPWpGaD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—VEGFA—liver cancer	0.00153	0.0345	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CYCS—liver cancer	0.00144	0.0324	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—SHC3—liver cancer	0.00134	0.03	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—IGF2—liver cancer	0.00127	0.0285	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—IGF2—liver cancer	0.00108	0.0242	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—ADAM17—liver cancer	0.00096	0.0216	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAPK14—liver cancer	0.000935	0.021	CbGpPWpGaD
Amifostine—Myocardial ischaemia—Sorafenib—liver cancer	0.000788	0.05	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—MMP2—liver cancer	0.000768	0.0173	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—liver cancer	0.000703	0.0158	CbGpPWpGaD
Amifostine—Hypocalcaemia—Sorafenib—liver cancer	0.000692	0.0439	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—RAF1—liver cancer	0.00068	0.0153	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CASP3—liver cancer	0.000611	0.0137	CbGpPWpGaD
Amifostine—ENPP1—Disease—APCS—liver cancer	0.000606	0.0136	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—JUN—liver cancer	0.000593	0.0133	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—MMP9—liver cancer	0.000592	0.0133	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MMP9—liver cancer	0.000577	0.013	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAPK8—liver cancer	0.000561	0.0126	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—VEGFA—liver cancer	0.000531	0.0119	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—STAT3—liver cancer	0.000513	0.0115	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—MMP9—liver cancer	0.000503	0.0113	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MAPK14—liver cancer	0.000501	0.0113	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—TGFB1—liver cancer	0.000488	0.011	CbGpPWpGaD
Amifostine—Dermatitis exfoliative—Sorafenib—liver cancer	0.000487	0.0309	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—APC—liver cancer	0.000464	0.0104	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—VEGFA—liver cancer	0.000452	0.0102	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—TGFB1—liver cancer	0.000415	0.00932	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.000414	0.0262	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—MAPK14—liver cancer	0.000391	0.00879	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—RAF1—liver cancer	0.000364	0.00819	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CG—liver cancer	0.000363	0.00816	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MTOR—liver cancer	0.000356	0.008	CbGpPWpGaD
Amifostine—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.000351	0.0223	CcSEcCtD
Amifostine—Acute coronary syndrome—Sorafenib—liver cancer	0.000349	0.0221	CcSEcCtD
Amifostine—Renal failure—Sorafenib—liver cancer	0.000348	0.0221	CcSEcCtD
Amifostine—Myocardial infarction—Sorafenib—liver cancer	0.000347	0.022	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—AKT1—liver cancer	0.000339	0.00762	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—AKT1—liver cancer	0.000331	0.00743	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CASP3—liver cancer	0.000327	0.00735	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—UGDH—liver cancer	0.000327	0.00735	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CD—liver cancer	0.000319	0.00717	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—JUN—liver cancer	0.000318	0.00714	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CTNNB1—liver cancer	0.000315	0.00709	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—EPT1—liver cancer	0.000308	0.00691	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MAPK8—liver cancer	0.000301	0.00676	CbGpPWpGaD
Amifostine—Erythema multiforme—Sorafenib—liver cancer	0.000301	0.0191	CcSEcCtD
Amifostine—Feeling hot—Epirubicin—liver cancer	0.000298	0.0189	CcSEcCtD
Amifostine—Flushing—Sorafenib—liver cancer	0.000295	0.0187	CcSEcCtD
Amifostine—ENPP1—Metabolism—TAT—liver cancer	0.000292	0.00655	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—AKT1—liver cancer	0.000288	0.00648	CbGpPWpGaD
Amifostine—Rigors—Epirubicin—liver cancer	0.000287	0.0182	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—RAF1—liver cancer	0.000285	0.0064	CbGpPWpGaD
Amifostine—Arrhythmia—Sorafenib—liver cancer	0.000284	0.018	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—MTOR—liver cancer	0.000278	0.00625	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CB—liver cancer	0.000278	0.00625	CbGpPWpGaD
Amifostine—Feeling hot—Doxorubicin—liver cancer	0.000276	0.0175	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—STAT3—liver cancer	0.000275	0.00618	CbGpPWpGaD
Amifostine—Rigors—Doxorubicin—liver cancer	0.000265	0.0168	CcSEcCtD
Amifostine—Hypocalcaemia—Epirubicin—liver cancer	0.000256	0.0162	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—JUN—liver cancer	0.000248	0.00558	CbGpPWpGaD
Amifostine—Syncope—Sorafenib—liver cancer	0.000248	0.0157	CcSEcCtD
Amifostine—Loss of consciousness—Sorafenib—liver cancer	0.000243	0.0154	CcSEcCtD
Amifostine—Hypertension—Sorafenib—liver cancer	0.000239	0.0152	CcSEcCtD
Amifostine—ENPP1—Disease—LTF—liver cancer	0.000237	0.00532	CbGpPWpGaD
Amifostine—Hypocalcaemia—Doxorubicin—liver cancer	0.000236	0.015	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—MAPK8—liver cancer	0.000235	0.00528	CbGpPWpGaD
Amifostine—Hiccups—Epirubicin—liver cancer	0.000234	0.0148	CcSEcCtD
Amifostine—Anaphylactic shock—Sorafenib—liver cancer	0.000226	0.0143	CcSEcCtD
Amifostine—Shock—Sorafenib—liver cancer	0.000222	0.0141	CcSEcCtD
Amifostine—Hiccups—Doxorubicin—liver cancer	0.000216	0.0137	CcSEcCtD
Amifostine—Dyspnoea—Sorafenib—liver cancer	0.000201	0.0128	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—HRAS—liver cancer	0.000201	0.00451	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GLUL—liver cancer	0.000198	0.00445	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CPT1B—liver cancer	0.000198	0.00445	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NR1H4—liver cancer	0.000191	0.00429	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTA3—liver cancer	0.000188	0.00422	CbGpPWpGaD
Amifostine—ENPP1—Disease—ALDOB—liver cancer	0.000183	0.00411	CbGpPWpGaD
Amifostine—Dermatitis exfoliative—Epirubicin—liver cancer	0.00018	0.0114	CcSEcCtD
Amifostine—Urticaria—Sorafenib—liver cancer	0.000179	0.0114	CcSEcCtD
Amifostine—Body temperature increased—Sorafenib—liver cancer	0.000179	0.0113	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—AKT1—liver cancer	0.000177	0.00398	CbGpPWpGaD
Amifostine—Anaphylactoid reaction—Epirubicin—liver cancer	0.000175	0.0111	CcSEcCtD
Amifostine—ENPP1—Metabolism—GSTA4—liver cancer	0.000172	0.00386	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CA—liver cancer	0.00017	0.00381	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTA2—liver cancer	0.000167	0.00376	CbGpPWpGaD
Amifostine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000167	0.0106	CcSEcCtD
Amifostine—Hypersensitivity—Sorafenib—liver cancer	0.000166	0.0106	CcSEcCtD
Amifostine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000162	0.0103	CcSEcCtD
Amifostine—ENPP1—Metabolism—GSTA1—liver cancer	0.000162	0.00363	CbGpPWpGaD
Amifostine—Cardiac arrest—Epirubicin—liver cancer	0.000161	0.0102	CcSEcCtD
Amifostine—Pruritus—Sorafenib—liver cancer	0.00016	0.0101	CcSEcCtD
Amifostine—ENPP1—Metabolism—NAT2—liver cancer	0.00016	0.00359	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—HRAS—liver cancer	0.000157	0.00352	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ALDOB—liver cancer	0.000153	0.00344	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000153	0.0097	CcSEcCtD
Amifostine—Cardiac arrest—Doxorubicin—liver cancer	0.000149	0.00948	CcSEcCtD
Amifostine—Dizziness—Sorafenib—liver cancer	0.000149	0.00947	CcSEcCtD
Amifostine—ENPP1—Metabolism—CRABP1—liver cancer	0.000146	0.00328	CbGpPWpGaD
Amifostine—ENPP1—Disease—ADAM17—liver cancer	0.000145	0.00325	CbGpPWpGaD
Amifostine—Vomiting—Sorafenib—liver cancer	0.000144	0.00911	CcSEcCtD
Amifostine—Rash—Sorafenib—liver cancer	0.000142	0.00903	CcSEcCtD
Amifostine—Dermatitis—Sorafenib—liver cancer	0.000142	0.00902	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000142	0.00898	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—AKT1—liver cancer	0.000138	0.00311	CbGpPWpGaD
Amifostine—ENPP1—Disease—PSMA4—liver cancer	0.000136	0.00305	CbGpPWpGaD
Amifostine—ENPP1—Disease—PSMD10—liver cancer	0.000136	0.00305	CbGpPWpGaD
Amifostine—Nausea—Sorafenib—liver cancer	0.000134	0.00851	CcSEcCtD
Amifostine—ENPP1—Disease—GOT2—liver cancer	0.000132	0.00297	CbGpPWpGaD
Amifostine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00013	0.00823	CcSEcCtD
Amifostine—Renal failure—Epirubicin—liver cancer	0.000129	0.00816	CcSEcCtD
Amifostine—ENPP1—Metabolism—HPGDS—liver cancer	0.000128	0.00287	CbGpPWpGaD
Amifostine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00012	0.00761	CcSEcCtD
Amifostine—Bradycardia—Epirubicin—liver cancer	0.00012	0.00759	CcSEcCtD
Amifostine—Renal failure—Doxorubicin—liver cancer	0.000119	0.00755	CcSEcCtD
Amifostine—ENPP1—Disease—GOT1—liver cancer	0.000114	0.00256	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PSMD10—liver cancer	0.000114	0.00256	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PSMA4—liver cancer	0.000114	0.00256	CbGpPWpGaD
Amifostine—Erythema multiforme—Epirubicin—liver cancer	0.000111	0.00705	CcSEcCtD
Amifostine—ENPP1—Metabolism—GOT2—liver cancer	0.000111	0.00249	CbGpPWpGaD
Amifostine—Bradycardia—Doxorubicin—liver cancer	0.000111	0.00702	CcSEcCtD
Amifostine—Flushing—Epirubicin—liver cancer	0.000109	0.00692	CcSEcCtD
Amifostine—Chills—Epirubicin—liver cancer	0.000105	0.00669	CcSEcCtD
Amifostine—ENPP1—Disease—PRKCE—liver cancer	0.000105	0.00237	CbGpPWpGaD
Amifostine—Arrhythmia—Epirubicin—liver cancer	0.000105	0.00666	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP2E1—liver cancer	0.000104	0.00234	CbGpPWpGaD
Amifostine—Erythema multiforme—Doxorubicin—liver cancer	0.000103	0.00652	CcSEcCtD
Amifostine—Flushing—Doxorubicin—liver cancer	0.000101	0.0064	CcSEcCtD
Amifostine—Chills—Doxorubicin—liver cancer	9.75e-05	0.00619	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYCS—liver cancer	9.74e-05	0.00219	CbGpPWpGaD
Amifostine—Arrhythmia—Doxorubicin—liver cancer	9.71e-05	0.00616	CcSEcCtD
Amifostine—ENPP1—Metabolism—GOT1—liver cancer	9.56e-05	0.00215	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GGT1—liver cancer	9.56e-05	0.00215	CbGpPWpGaD
Amifostine—Ill-defined disorder—Epirubicin—liver cancer	9.49e-05	0.00602	CcSEcCtD
Amifostine—Malaise—Epirubicin—liver cancer	9.22e-05	0.00585	CcSEcCtD
Amifostine—ENPP1—Disease—H2AFX—liver cancer	9.18e-05	0.00206	CbGpPWpGaD
Amifostine—Syncope—Epirubicin—liver cancer	9.17e-05	0.00582	CcSEcCtD
Amifostine—Loss of consciousness—Epirubicin—liver cancer	8.99e-05	0.0057	CcSEcCtD
Amifostine—Convulsion—Epirubicin—liver cancer	8.86e-05	0.00562	CcSEcCtD
Amifostine—Hypertension—Epirubicin—liver cancer	8.83e-05	0.0056	CcSEcCtD
Amifostine—Ill-defined disorder—Doxorubicin—liver cancer	8.78e-05	0.00557	CcSEcCtD
Amifostine—Chest pain—Epirubicin—liver cancer	8.71e-05	0.00552	CcSEcCtD
Amifostine—Discomfort—Epirubicin—liver cancer	8.6e-05	0.00546	CcSEcCtD
Amifostine—ENPP1—Metabolism—GSTP1—liver cancer	8.59e-05	0.00193	CbGpPWpGaD
Amifostine—Malaise—Doxorubicin—liver cancer	8.53e-05	0.00541	CcSEcCtD
Amifostine—Syncope—Doxorubicin—liver cancer	8.49e-05	0.00538	CcSEcCtD
Amifostine—ENPP1—Metabolism—HMOX1—liver cancer	8.47e-05	0.0019	CbGpPWpGaD
Amifostine—Anaphylactic shock—Epirubicin—liver cancer	8.35e-05	0.00529	CcSEcCtD
Amifostine—ENPP1—Disease—MTHFR—liver cancer	8.33e-05	0.00187	CbGpPWpGaD
Amifostine—Loss of consciousness—Doxorubicin—liver cancer	8.32e-05	0.00528	CcSEcCtD
Amifostine—ENPP1—Disease—TERT—liver cancer	8.3e-05	0.00187	CbGpPWpGaD
Amifostine—Shock—Epirubicin—liver cancer	8.21e-05	0.00521	CcSEcCtD
Amifostine—Convulsion—Doxorubicin—liver cancer	8.2e-05	0.0052	CcSEcCtD
Amifostine—Hypertension—Doxorubicin—liver cancer	8.17e-05	0.00518	CcSEcCtD
Amifostine—Tachycardia—Epirubicin—liver cancer	8.15e-05	0.00517	CcSEcCtD
Amifostine—Chest pain—Doxorubicin—liver cancer	8.06e-05	0.00511	CcSEcCtD
Amifostine—Discomfort—Doxorubicin—liver cancer	7.96e-05	0.00505	CcSEcCtD
Amifostine—ENPP1—Metabolism—GSTM1—liver cancer	7.89e-05	0.00177	CbGpPWpGaD
Amifostine—Hypotension—Epirubicin—liver cancer	7.8e-05	0.00495	CcSEcCtD
Amifostine—Anaphylactic shock—Doxorubicin—liver cancer	7.72e-05	0.0049	CcSEcCtD
Amifostine—Shock—Doxorubicin—liver cancer	7.6e-05	0.00482	CcSEcCtD
Amifostine—Tachycardia—Doxorubicin—liver cancer	7.54e-05	0.00478	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP1A1—liver cancer	7.48e-05	0.00168	CbGpPWpGaD
Amifostine—Dyspnoea—Epirubicin—liver cancer	7.44e-05	0.00472	CcSEcCtD
Amifostine—Somnolence—Epirubicin—liver cancer	7.42e-05	0.00471	CcSEcCtD
Amifostine—Hypotension—Doxorubicin—liver cancer	7.22e-05	0.00458	CcSEcCtD
Amifostine—ENPP1—Disease—APC—liver cancer	7e-05	0.00157	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—MTHFR—liver cancer	6.97e-05	0.00157	CbGpPWpGaD
Amifostine—Dyspnoea—Doxorubicin—liver cancer	6.89e-05	0.00437	CcSEcCtD
Amifostine—Feeling abnormal—Epirubicin—liver cancer	6.88e-05	0.00436	CcSEcCtD
Amifostine—Somnolence—Doxorubicin—liver cancer	6.87e-05	0.00435	CcSEcCtD
Amifostine—ENPP1—Metabolism—PPARA—liver cancer	6.84e-05	0.00154	CbGpPWpGaD
Amifostine—Urticaria—Epirubicin—liver cancer	6.63e-05	0.00421	CcSEcCtD
Amifostine—Body temperature increased—Epirubicin—liver cancer	6.6e-05	0.00419	CcSEcCtD
Amifostine—ENPP1—Disease—BRAF—liver cancer	6.58e-05	0.00148	CbGpPWpGaD
Amifostine—Feeling abnormal—Doxorubicin—liver cancer	6.36e-05	0.00404	CcSEcCtD
Amifostine—Hypersensitivity—Epirubicin—liver cancer	6.15e-05	0.0039	CcSEcCtD
Amifostine—ENPP1—Disease—PIK3CD—liver cancer	6.15e-05	0.00138	CbGpPWpGaD
Amifostine—Urticaria—Doxorubicin—liver cancer	6.14e-05	0.00389	CcSEcCtD
Amifostine—Body temperature increased—Doxorubicin—liver cancer	6.11e-05	0.00387	CcSEcCtD
Amifostine—ENPP1—Disease—SERPINE1—liver cancer	6.08e-05	0.00137	CbGpPWpGaD
Amifostine—Pruritus—Epirubicin—liver cancer	5.91e-05	0.00375	CcSEcCtD
Amifostine—ENPP1—Metabolism—PIK3CG—liver cancer	5.86e-05	0.00132	CbGpPWpGaD
Amifostine—Hypersensitivity—Doxorubicin—liver cancer	5.69e-05	0.00361	CcSEcCtD
Amifostine—ENPP1—Metabolism—PPARG—liver cancer	5.65e-05	0.00127	CbGpPWpGaD
Amifostine—Dizziness—Epirubicin—liver cancer	5.52e-05	0.0035	CcSEcCtD
Amifostine—ENPP1—Disease—RAF1—liver cancer	5.49e-05	0.00123	CbGpPWpGaD
Amifostine—Pruritus—Doxorubicin—liver cancer	5.46e-05	0.00347	CcSEcCtD
Amifostine—ENPP1—Disease—PIK3CB—liver cancer	5.36e-05	0.0012	CbGpPWpGaD
Amifostine—ENPP1—Disease—MTOR—liver cancer	5.36e-05	0.0012	CbGpPWpGaD
Amifostine—Vomiting—Epirubicin—liver cancer	5.31e-05	0.00337	CcSEcCtD
Amifostine—Rash—Epirubicin—liver cancer	5.26e-05	0.00334	CcSEcCtD
Amifostine—Dermatitis—Epirubicin—liver cancer	5.26e-05	0.00334	CcSEcCtD
Amifostine—ENPP1—Metabolism—PIK3CD—liver cancer	5.15e-05	0.00116	CbGpPWpGaD
Amifostine—Dizziness—Doxorubicin—liver cancer	5.11e-05	0.00324	CcSEcCtD
Amifostine—ENPP1—Metabolism—ALB—liver cancer	5.08e-05	0.00114	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN1B—liver cancer	5.03e-05	0.00113	CbGpPWpGaD
Amifostine—Nausea—Epirubicin—liver cancer	4.96e-05	0.00314	CcSEcCtD
Amifostine—Vomiting—Doxorubicin—liver cancer	4.91e-05	0.00311	CcSEcCtD
Amifostine—Rash—Doxorubicin—liver cancer	4.87e-05	0.00309	CcSEcCtD
Amifostine—Dermatitis—Doxorubicin—liver cancer	4.87e-05	0.00309	CcSEcCtD
Amifostine—ENPP1—Disease—CTNNB1—liver cancer	4.75e-05	0.00107	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN1A—liver cancer	4.64e-05	0.00104	CbGpPWpGaD
Amifostine—Nausea—Doxorubicin—liver cancer	4.59e-05	0.00291	CcSEcCtD
Amifostine—ENPP1—Metabolism—PIK3CB—liver cancer	4.49e-05	0.00101	CbGpPWpGaD
Amifostine—ENPP1—Disease—STAT3—liver cancer	4.14e-05	0.000931	CbGpPWpGaD
Amifostine—ENPP1—Disease—MYC—liver cancer	3.85e-05	0.000865	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFB1—liver cancer	3.84e-05	0.000863	CbGpPWpGaD
Amifostine—ENPP1—Disease—KRAS—liver cancer	3.56e-05	0.000799	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CA—liver cancer	3.27e-05	0.000734	CbGpPWpGaD
Amifostine—ENPP1—Disease—HRAS—liver cancer	3.02e-05	0.000679	CbGpPWpGaD
Amifostine—ENPP1—Disease—IL6—liver cancer	2.89e-05	0.00065	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CA—liver cancer	2.74e-05	0.000615	CbGpPWpGaD
Amifostine—ENPP1—Disease—AKT1—liver cancer	2.67e-05	0.0006	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AKT1—liver cancer	2.24e-05	0.000502	CbGpPWpGaD
